02273.HK
Gushengtang Holdings Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 27.56
+1.10%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.5B | 3.2B | 3.0B | 2.3B | 1.6B |
| Cost of Revenue | 4.5B | 2.2B | 2.1B | 1.6B | 1.1B |
| Gross Profit | 2.0B | 1.0B | 909.3M | 700.0M | 499.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 1.2B | 564.3M | 553.4M | 436.1M | 307.5M |
| General & Admin Expense | 365.8M | 191.9M | 184.7M | 154.7M | 100.2M |
| Selling & Marketing Expense | 787.9M | 372.4M | 368.7M | 281.4M | 207.3M |
| Other Expenses | (7.1M) | — | (9.6M) | — | — |
| Total Operating Expenses | 1.1B | 564.3M | 543.8M | 436.1M | 307.5M |
| Cost and Expenses | 5.7B | 2.8B | 2.7B | 2.1B | 1.4B |
| Operating Income (EBIT) | 869.0M | 448.1M | 356.0M | 278.9M | 192.0M |
| Non-Operating | |||||
| Interest Income | 30.7M | 15.7M | 25.0M | 18.5M | 14.1M |
| Interest Expense | 36.1M | 26.1M | 17.6M | 25.6M | 17.6M |
| Net Interest Income | (18.1M) | (10.5M) | 7.4M | (7.1M) | (3.6M) |
| Other Non-Op Income/Expense | 43.6M | (24.4M) | 7.3M | 5.3M | 6.7M |
| Non-Operating Income (excl Interest) | 25.6M | 23.8M | 11.3M | (30.8M) | 5.0M |
| EBT (Pre-Tax Income) | 909.2M | 423.6M | 363.3M | 284.2M | 198.7M |
| Income Tax Expense | 141.1M | 71.6M | 56.1M | 31.2M | 17.6M |
| Bottom Line | |||||
| Net Income | 770.3M | 352.8M | 306.8M | 252.2M | 180.9M |
| Earnings from Cont. Ops | 771.2M | 352.1M | 307.2M | 252.9M | 181.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 773.4M | 352.8M | 306.8M | 252.2M | 180.9M |
| Per Share | |||||
| Basic EPS | HK$3.25 | HK$1.45 | HK$1.22 | HK$1.03 | HK$0.79 |
| Diluted EPS | HK$3.15 | HK$1.45 | HK$1.22 | HK$1.03 | HK$0.76 |
| Revenue Per Share | HK$29.64 | HK$13.40 | HK$12.04 | HK$9.51 | HK$7.05 |
| Shares | |||||
| Basic Shares Outstanding | 220.5M | 242.5M | 251.0M | 244.2M | 230.3M |
| Diluted Shares Outstanding | 242.2M | 242.5M | 251.0M | 244.2M | 239.0M |
| Profitability Metrics | |||||
| EBITDA | 1.0B | 485.7M | 375.0M | 429.9M | 324.2M |
| D&A | 177.0M | 61.5M | 30.4M | 120.2M | 107.9M |
| EBIT | 843.4M | 424.2M | 344.7M | 309.7M | 216.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026